Skip to main
FUSN
FUSN logo

Fusion Pharmaceuticals (FUSN)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Fusion Pharmaceuticals (FUSN) Stock

About Fusion Pharmaceuticals (FUSN)

Fusion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It develops GMP manufacturing of radiopharmaceuticals for the diagnosis and treatment of disease. The company was founded by John Vaillant in 2014 and is headquartered in Hamilton, Canada.
Market cap$1.83B
Today's volume
Revenue (TTM)$2.04M
Avg. daily volume1.84M
EBITDA (TTM)-$107.54M
Open
Price / earnings ratio-15.21x
Today's range
Debt / equity26.69x
52 week range$2.31 - $21.6
5 year debt / equity12.42x
Beta (LTM)0.55x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio10.64x
Ex-dividend date
Next earningsDec 10, 2024
Dividend payable date

Fusion Pharmaceuticals Stock Rating

What analysts recommend for FUSN stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 18%
Buy 27%
Hold 55%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jun 16, 2025, the market cap for FUSN stock is $1.84B

The current P/E ratio for FUSN stock is -15.21

The 52-week high for FUSN stock is $21.60. The current FUSN stock price $undefined is 100.00% below its 52-week high

The 52-week low for FUSN stock is $2.31. The current FUSN stock price $undefined has increased 100.00% from its 52-week low

No, the FUSN stock does not pay dividends to its shareholders

The target price for FUSN stock is $17.09 based on the average of what a group of analyst think FUSN stock could be worth at a future date. This is not a prediction by Public.com

How to buy FUSN stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in FUSN stock

    Navigate to the Explore page. Then, type FUSN into the search bar. When you see FUSN stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased FUSN stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Fusion Pharmaceuticals Stock Earnings

The value each FUSN share was expected to gain vs. the value that each FUSN share actually gained.

Fusion Pharmaceuticals (FUSN) reported Q1 2024 earnings per share (EPS) of -$0.40, missing estimates of -$0.37 by 8.11%. In the same quarter last year, Fusion Pharmaceuticals's earnings per share (EPS) was -$0.45. Fusion Pharmaceuticals is expected to release next earnings on 12/10/2024, with an earnings per share (EPS) estimate of $0.

Buy Fusion Pharmaceuticals (FUSN) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.